Sunday, October 18, 2009: 6:30 PM
Grand Ballroom, Salons 1 & 2 (Renaissance Hollywood Hotel)
* Candidate for the Lee B. Lusted Student Prize Competition
Click on the Individual Presentation Titles to view the abstract details.
Click here to view Poster Number Acronyms
* DETECTING BLOOD LABORATORY ERRORS USING A BAYESIAN NETWORK: AN EVALUATION ON LIVER ENZYME TESTS
Quang A. Le, Pharm.D.1, Gregory B. Strylewicz, PhD2 and Jason N. Doctor, PhD1, (1)University of Southern California, Los Angeles, CA, (2)University of Washington, Seattle, WA
* BAYESIAN UPDATING BASED ON THE PATIENT PSA HISTORY TO OPTIMIZE PROSTATE BIOPSY REFERRAL DECISIONS
Jingyu Zhang, MS1, Brian T. Denton, PhD1, Hari Balasubramanian, PhD2, Nilay D. Shah, PhD3 and Brant Inman, MD4, (1)North Carolina State University, Raleigh, NC, (2)University of Massachusetts, Amherst, MA, (3)Mayo Clinic, Rochester, MN, (4)Duke University, Durham, NC
* ESTIMATING SOCIETAL WILLINGNESS TO PAY BASED ON THE ATP III GUIDELINES FOR THE OPTIMAL START TIME FOR STATINS
Jennifer E. Mason, MS1, Brian T. Denton, PhD1, Nilay D. Shah, PhD2 and Steven Smith, MD3, (1)North Carolina State University, Raleigh, NC, (2)Mayo Clinic, Rochester, MN, (3)Mayo Clinic College of Medicine, Rochester, MN
* SUPERIOR PERFORMANCE OF BAYESIAN NETWORKS IN PREDICTING THE RISK OF INVASIVE VERSUS IN-SITU BREAST CANCER IN OLDER WOMEN
Mehmet Ayvaci, MS1, Oguzhan Alagoz, PhD1, Jagpreet Chhatwal, PhD2, Edward A. Sickles, MD3, Elizabeth S. Burnside, MD, MPH, MS1 and Houssam Nassif4, (1)University of Wisconsin-Madison, Madison, WI, (2)Merck Research Laboratories, North Wales, PA, (3)University of California San Francisco School of Medicine, San Francisco, CA, (4)University of Wisconsin, Madison, WI
* EFFECTIVENESS AND COST-EFFECTIVENESS OF VACCINATION FOR NOVEL INFLUENZA A (H1N1)
David W. Hutton, MS1, Nayer Khazeni, MD, MS1, Alan Garber, MD, PhD2, Nathaniel Hupert, MD, MPH3 and Douglas K. Owens, MD, MS2, (1)Stanford University, Stanford, CA, (2)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA, (3)Weill Medical College, Cornell University, New York, NY
* COMPARING CENTERS BASED ON OUTCOME: CALCULATION OF EXPECTED RANK FOR BETTER INTERPRETATION
Hester F. Lingsma, MSc1, Marinus J. C. Eijkemans, PhD1, Diederik Dippel, MD, PhD2, J.C. Van Houwelingen, PhD3 and Ewout W. Steyerberg, PhD4, (1)Erasmus MC, Rotterdam, Netherlands, (2)ErasmusMC, Rotterdam, Netherlands, (3)Leiden University Medical Center, Leiden, Netherlands, (4)Department of Public Health, AE 236, Rotterdam, Netherlands
* COST-EFFECTIVENESS OF CT CALCIUM SCORING AND CT CORONARY ANGIOGRAPHY IN THE DIAGNOSIS OF CORONARY ARTERY DISEASE: THE INFLUENCE OF REDUCED RADIATION EXPOSURE
Tessa S.S. Genders, MSc, Annick C. Weustink, MD, Nico R. Mollet, MD, PhD, Pim J. de Feyter, MD, PhD and Myriam G.M. Hunink, PhD, MD, Erasmus MC, Rotterdam, Netherlands
* HIV TESTING AND TREATMENT: IMPLICATIONS FOR EPIDEMIC CONTROL IN SOUTH AFRICA
Eran Bendavid, MD1, Robin Wood, FCP, MMed, DTM&H2, Margaret L. Brandeau, PhD1 and Douglas K. Owens, MD, MS3, (1)Stanford University, Stanford, CA, (2)University of Cape Town, Cape Town, South Africa, (3)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA
* THE COST EFFECTIVENESS OF SCREENING FOR VASA PREVIA AT 18-20 WEEKS GESTATION IN ONTARIO
Lauren E. Cipriano, BSc, BA, PhD Candidate, Stanford University, Stanford, CA, William H. Barth Jr., MD, Massachusetts General Hospital, Boston, MA and Gregory S. Zaric, PhD, University of Western Ontario, London, ON, Canada
* COST-EFFECTIVENESS ANALYSIS OF UNIVERSAL TB SCREENING FOR CHILDREN—FACING UP TO COMPLEXITY IN HIGH BURDEN COUNTRIES
Jennifer Jane Schneider, MD, VA Palo Alto, Palo Alto, CA, Patricia Foo, Stanford University, Stanford, CA and Douglas K. Owens, MD, MS, Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA
* RISK AND PREGNANCY: A MIXED METHODS STUDY OF DECISION MAKING FOR FIRST TRIMESTER PRENATAL GENETIC SCREENING
Ruth M. Farrell, MD, MA1, Natasha Dolgin, BA1, Victoria A. Winbush, PhD, MPH, LiSW2 and Christian Simon, PhD3, (1)Cleveland Clinic, Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH, (3)University of Iowa, Iowa City, IA
* DISEASE MODIFYING OSTEOARTHRITIS DRUGS (DMOADS) IN KNEE OSTEOARTHRITIS (OA): CAN THEY BE COST-EFFECTIVE?
Elena Losina, PhD1, Nina N. Niu, BA1, Lisa G. Suter, MD2, David J. Hunter, PhD, MBBS3, Holly L. Holt, BS1, Hanna Gerlovin, BA1, William M. Reichmann, MA1, Daniel H. Solomon, MD, MPH1, Rochelle P. Walensky, MD, MPH4, A. David Paltiel, PhD2 and Jeffrey N. Katz, MD, MS1, (1)Brigham and Women's Hospital, Boston, MA, (2)Yale University School of Medicine, New Haven, CT, (3)New England Baptist Hospital, Boston, MA, (4)Harvard Medical School, Boston, MA
* BENEFIT-RISK ANALYSIS OF ISONIAZID (INH) FOR TREATMENT OF LATENT TUBERCULOSIS INFECTION (LTBI)
Mohsen Sadatsafavi, MD, MHSc1, Carlo A. Marra, PharmD, PhD1, Larry D. Lynd, PhD1, Fawziah Marra, PharmD1, Jiamei Liu, MSc1, Onofre Mendoza, MD., PhD2, Michael Tan, MA3, R. Kevin Elwood, MD4 and J. Mark FitzGerald, MD, FRCPC3, (1)University of British Columbia, Vancouver, BC, Canada, (2)Queen's university, Vancouver, BC, Canada, (3)Vancouver Coastal Health Research Institute, Vancouver, BC, Canada, (4)BC Centre for Disease Control, Vancouver, BC, Canada
* THE QUALITY OF DECISIONS ABOUT BREAST CANCER SURGERY
Clara Lee, MD, MPP1, Jeffrey K. Belkora, PhD2, Yuchiao Chang, PhD3, Carol Cosenza, MSW4, Carrie A. Levin, PhD5, Beverly Moy, MD, MPH3, Ann Partridge, MD, MPH6 and Karen R. Sepucha, PhD3, (1)University of North Carolina Chapel Hill, Chapel Hill, NC, (2)University of California, San Francisco, San Francisco, CA, (3)Massachusetts General Hospital, Boston, MA, (4)University of Massachusetts Boston, Boston, MA, (5)Foundation for Informed Medical Decision Making, Boston, MA, (6)Dana-Farber Cancer Institute, Boston, MA
* USING INFORMATION ABOUT MARGIN STATUS IN THE TREATMENT STRATEGIES FOR DUCTAL CARCINOMA IN SITU OF BREAST: A DECISION ANALYSIS
Shi-Yi Wang, MD, MS, Todd M. Tuttle, MD, MS, Robert L. Kane, MD and Karen M. Kuntz, ScD, University of Minnesota, Minneapolis, MN
* WHAT TEST CHARACTERISTICS ARE NEEDED FOR NEW TESTS TO EVALUATE CARDIOVASCULAR PREVENTION STRATEGIES?
Brandon B. Woodbury, MD1, David J. Bryg, PhD1 and Robert J. Bryg, MD2, (1)Olive View-Medical Center, Sylmar, CA, (2)Cardiology, Sylmar, CA
* DO INTERNISTS AND FAMILY PRACTITIONERS DIFFER IN THEIR DIAGNOSIS AND MANAGEMENT OF THE SAME PATIENT WITH HEART DISEASE?
Rebecca Shackelton, ScM1, Carol L. Link, PhD2, Lisa D. Marceau, MPH2 and John B. McKinlay, PhD2, (1)New England Research Institutes, Inc., Watertown, MA, (2)Neri, Watertown, MA
* THE INTENDED AND UNINTENDED CONSEQUENCES OF CLINICAL GUIDELINES
Rebecca Shackelton, ScM1, Carol L. Link, PhD2, Lisa D. Marceau, MPH2 and John B. McKinlay, PhD2, (1)New England Research Institutes, Inc., Watertown, MA, (2)Neri, Watertown, MA
* GLOBAL CERVICAL CANCER PREVENTION – A COLLABORATIVE APPROACH TO MODEL DEVELOPMENT AND POLICY APPLICATION
Meredith O'Shea, MA1, Jane J. Kim, PhD1, Mireia Diaz Sanchis2, Gary M. Clifford3, Silvia Franceschi3, Silvia de Sanjose, MD, PhD2, F. Xavier Bosch, MD, PhD2 and Sue J. Goldie, MD, MPH1, (1)Harvard School of Public Health, Boston, MA, (2)Catalan Institute of Oncology, Barcelona, Spain, (3)International Agency for Research on Cancer, Lyon, France
* MODELING OF THE DECISION TO TREAT ANEMIC CHRONIC KIDNEY DISEASE (CKD) PATIENTS WITH TRANSFUSION OR ERYTHROPOIESIS STIMULATING AGENTS (ESA'S)
John L. Adams, PhD1, Jeffrey C. Fink, MD, MS2, Stephen L. Seliger, MD, MS2, Loreen Walker, BS2, Van Doren Hsu, PharmD2, Kathleen M. Fox, PhD3, Brian D. Bradbury, DSc4 and Shravanthi R. Gandra, PhD, MBA4, (1)RAND Corporation, Santa Monica, CA, (2)University of Maryland, Baltimore, MD, (3)Strategic Healthcare Solutions, LLC, Monkton, MD, (4)Amgen, Thousand Oaks, CA
* ADDING VALUE THROUGH THE PROCESS OF DEVELOPING AN EXPERT SYSTEM
Bruce W. Morlan, MS1, Henry H. Ting, M.D.2, Nilay D. Shah, PhD1 and Rick A. Nishimura, M.D., CV2, (1)Mayo Clinic, Rochester, MN, (2)Mayo Clinic College of Medicine, Rochester, MN
* CARDIOLOGISTS' THOUGHTS ON DECISION MAKING SURROUNDING IMPLANTABLE CARDIOVERTER DEFIBRILLATORS: A QUALITATIVE STUDY
Dan D. Matlock, MD1, Carolyn Nowels, MSPH1, Debbi Main, PhD2, Pamela Peterson, MD, MSPH3, Fred Masoudi, MD, MSPH3 and Jean S. Kutner, MD, MSPH1, (1)The University of Colorado Denver, Aurora, CO, (2)University of Colorado Denver, Denver, CO, (3)Denver Health Medical Center, Division of Cardiology, Denver, CO
* DECISIONS ON DRUG THERAPIES BY NUMBER NEEDED TO TREAT AND GAIN IN DISEASE FREE SURVIVAL: A RANDOMIZED SURVEY OF MEDICAL DOCTORS
Peder A. Halvorsen, MD, PhD, University of Tromsø, Norway, 9516 Alta, Norway, Torbjørn F. Wisløff, M.Sc., Norwegian Health Services Research Centre, Oslo 0130, Norway, Olaf Gjerløw Aasland, MD, PhD, The Norwegian Medical Association, Oslo, Norway and Ivar Sønbø Kristiansen, MD, PhD, MPH, Institute of Health Economics, N-0317 Oslo, Denmark Norway
* OPTIMISM, GOD, TRUST, AND HEALTH: THE RELATIONSHIP OF HEALTH LITEARCY TO PSYCHOLOGICAL TRAITS
Marilyn Schapira, MD, MPH1, Joan Neuner, MD, MPH1, Mary Ann Gilligan, MD, MPH1, Prakash Laud, Ph.D.1, Elizabeth Hayes, PhD2 and Kathlyn Fletcher, MD, MPH3, (1)Medical College of Wisconsin, Milwaukee, WI, (2)Arizona State University, Tempe AZ, AZ, (3)Medical, Milwaukee, WI
* THE ‘VALUE' OF VALUES CLARIFICATION IN A DECISION AID: EVIDENCE FROM A RANDOMIZED CONTROLLED TRIAL AND QUALITATIVE EXIT INTERVIEWS
Deb Feldman-Stewart, PhD1, Michael Brundage, MD, MSc1, Christine Tong, MA1, Rob Siemens, MD1, Shabbir MH Alibhai, MD2, Tom Pickles, MD3 and John Robinson, PhD4, (1)Queen's University, Kingston, ON, Canada, (2)University Health Network, Toronto, ON, Canada, (3)BC Cancer Agency, Vancouver, BC, Canada, (4)Tom Baker Cancer Centre, Calgary, AB, Canada
* THE EFFECTS OF COMPUTER SIMULATED ABDOMINAL AORTIC ANEURYSM OUTCOMES ON PHYSICIAN DECISIONS TO GO TO SURGERY: A RANDOMIZED TRIAL
Joshua Hemmerich, PhD1, Arthur Elstein, PhD2, Margaret L. Schwarze, MD3, Elizabeth Moliski, MS, MBA1 and William Dale, MD, PhD1, (1)University of Chicago, Chicago, IL, (2)The University of Illinois at Chicago, Wilmette, IL, (3)University of Wisconsin, Madison, WI
* A QUALITATIVE PILOT STUDY OF PROSTATE CANCER SURVIVORS' PERCEPTIONS OF INFORMED DECISION MAKING ON SCREENING IN UNAFFECTED FIRST-DEGREE RELATIVES
Clement Gwede, PhD, MPH, RN, Shaenelle Wilson, MPH, Will Tarver, MPH, MLIS, Susan Vadaparampil, PhD, Brian Rivers, PhD, DaoHai Yu, PhD, Randy Heysek, MD, Javier Torres-Roca, MD, Philippe Spiess, MD, Julio Pow-Sang, MD, Cathy Meade, PhD and Paul B. Jacobsen, PhD, Moffitt Cancer Center, Tampa, FL
* PREDICTING SIX-YEAR HEART FAILURE RISK IN DIABETIC PATIENTS
Brian J. Wells, MD, MS1, Anil Jain, MD1, Susana Arrigain, MA1, Changhong Yu, MS1, Wayne A. Jr Rosenkrans, PhD2 and Michael W. Kattan, PhD1, (1)Cleveland Clinic, Cleveland, OH, (2)SciTech Strategies, Berwyn, PA
* WHAT MAKES A DECISION SHARED? PATIENT AND OBSERVER PERCEPTIONS
Tracy Wunderlich, MA1, Greg Cooper, MD2, George Divine, PhD1, Susan A. Flocke, PhD2, Nancy Oja-Tebbe, BS1, Kurt Stange, MD2 and Jennifer Elston Lafata, PhD1, (1)Henry Ford Health System, Detroit, MI, (2)Case Western Reserve University, Cleveland, OH
* INFORMED DECISION MAKING ON PRENATAL SCREENING AND EMOTIONAL WELL-BEING
Danielle R.M. Timmermans, PhD1, Johanna H. Kleinveld, PhD2, Matthijs Van den Berg, PhD2, Leo Ten Kate, PhD, MD2 and John MG Van Vugt, PhD, MD2, (1)EMGO Institute/ VU University Medical Center, Amsterdam, Netherlands, (2)VU University Medical Center, Amsterdam, Netherlands
* CHOICE OF TRANSFORMATION OF NEGATIVE UTILITIES: IMPACT ON FINAL TARIFFS
Liv Ariane Augestad, MD1, Kim Rand-Hendriksen, Cand.Psychol1, Knut Stavem, MD, PhD1 and Ivar Sønbø Kristiansen, MD, PhD, MPH2, (1)Akershus University Hospital, Lørenskog, Norway, (2)Institute of Health Economics, N-0317 Oslo, Denmark Norway
* MODELING HETEROGENEITY IN PATIENTS' PREFERENCES FOR INSULIN DELIVERY – A LATENT CLASS ANALYSIS OF A DISCRETE CHOICE EXPERIMENT
Larry D. Lynd, PhD1, Lindsey Colley, MSc1, Camila Guimaraes, PhD1, Carlo A. Marra, PharmD, PhD1, Sabrina Gill, MD1, Scot Simpson, PharmD, MSc2, Graydon Meneilly, MD1 and Regina HC Queiroz, MSc, PhD3, (1)University of British Columbia, Vancouver, BC, Canada, (2)University of Alberta, Edmonton, AB, Canada, (3)University of Sal Paulo, Ribeirao Preto Sao Paulo, Brazil
* MEASURING IMPACT OF OBESITY ON HEALTH-RELATED QUALITY OF LIFE USING SIX STANDARD INDEXES AND THREE SUMMARY MEASURES
Tanya G.K. Bentley, PhD1, Mari Palta, PhD2, Adam Paulsen2, David Feeny, PhD3, Dasha Cherepanov, PhD2, Nancy Cross Dunham, PhD2, Robert M. Kaplan, PhD4 and Dennis G. Fryback, PhD5, (1)Partnership for Health Analytic Research, LLC, Beverly Hills, CA, (2)University of Wisconsin, Madison, WI, (3)Health Utilities, Inc., and Kaiser Permanente Northwest Center for Health Research, Portland, OR, (4)University of California Los Angeles, Los Angeles, CA, (5)University of Wisconsin - Madison, Madison, WI
* A SYSTEMATIC APPROACH TO CALIBRATION ANALYSIS OF DECISION MODELS FOR HEALTH TECHNOLOGY ASSESSMENT
Ba' Pham, MSc, PhD, (c)1, George Tomlinson, PhD2, Paul Grootendorst, PhD3, William Witteman, MISt2, Harindra C. Wijeysundera, MD4 and Murray D. Krahn, MD, MSc2, (1)Toronto Health Economics and Technology Assessment Collaborative, Toronto, ON, Canada, (2)University of Toronto, Toronto, ON, Canada, (3)Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada, (4)Schulich Heart Center, Sunnybrook Health Sciences Center, Toronto, ON, Canada
* CONJOINT ANALYSIS AND ANALYTIC HIERARCHY PROCESS TO DETERMINE PREFERENCES FOR HEALTH INTERVENTIONS
Janine A. van Til, MSc, Universiteit Twente, Enschede, Netherlands, James G. Dolan, MD, University of Rochester, Rochester, NY, Anne M. Stiggelbout, PhD, Leiden University Medical Center, Leiden, Netherlands and Maarten J. IJzerman, PhD, University of Twente, Enschede, Netherlands
